Akèy › Myelom Miltip › Kalifòni › Irvine
Etid klinik pou Myelom Miltip nan Irvine, CA
14 etid pou Myelom Miltip ap chèche patisipan nan sit nan ak bò kote Irvine (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
Ap rekriteFaz 2
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Ap rekriteFaz 1
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 279067, Irvine
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Ap rekriteFaz 1
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Ap rekriteFaz 1/2
- City of Hope Irvine Lennar, Irvine
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Ap rekriteFaz 3
- UC Irvine Health Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Ap rekriteFaz 3
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
Ap rekriteFaz 2
- City of Hope at Irvine Lennar, Irvine
A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
Ap rekriteFaz 1/2
- City of Hope - Lennar, Irvine
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Ap rekriteFaz 3
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
Ap rekriteFaz 3
- City of Hope - Lennar Foundation Cancer Center, Irvine
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
Ap rekriteFaz 1/2
- Research Site, Irvine
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Ap rekriteFaz 1/2
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 277911, Irvine
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
Ap rekriteFaz 4
- UCI Health - Irvine Infusion Pharmacy ACC, Irvine
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- City of Hope at Irvine Lennar, Irvine
Etid Myelom Miltip nan lòt vil
- New York City, NY60 etid
- Boston, MA42 etid
- Atlanta, GA41 etid
- Houston, TX38 etid
- Durham, NC37 etid
- Nashville, TN32 etid
- Denver, CO27 etid
- Rochester, MN24 etid
- St. Louis, MO24 etid
- Columbus, OH24 etid
- Baldwin Park, CA23 etid
- Chicago, IL22 etid
Lòt etid nan Irvine
- Kansè Poumon ki pa ti selil25 etid
- Kansè nan tete23 etid
- Kansè (tout kalite)16 etid
- Kansè Metastatik16 etid
- Kansè poumon15 etid
- Kansè pwostat14 etid
- Kansè ovè12 etid
- Maladi Alzheimer11 etid
- Karsinòm selil skuamèz tèt ak kou11 etid
- Kansè vejik11 etid
- Kansè kolorektal10 etid
- Kansè pankreyas10 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.